Diagnosis and Treatment of Penile Cancer
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Genitourinary Oncology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 191
Special Issue Editor
Interests: urology; uro-oncology; robotic surgery; renal cancer; prostate cancer; testis cancer; penile cancer; bladder cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Penile cancer is a rather rare malignancy and a potentially mutilating disease. Recent years have seen advancements in our understanding of the development of penile cancer, the risk factors associated with its onset, and the clinical and histological precursor lesions linked to this condition. Moreover, conservative and radical treatments can be disfiguring and may have an impact on sexual function, quality of life, social interactions, self-image, and self-esteem.
The aim of this Special Issue is to collect original articles, reviews, and meta-analyses from distinguished authors who have practical experience in researching innovations in the diagnosis, treatment, and prognosis of penile cancer.
The specific interests of this Special Issue include the following:
- Epidemiological trends;
- Risk factors;
- Novel biomarkers;
- Sexual function and quality of life post treatment;
- Oncological follow-up.
We look forward to receiving your contributions.
Dr. Sisto Perdonà
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- penile cancer
- surgical treatment
- diagnosis
- biomarkers
- lymph-node status
